Bio-Gene Technology Ltd.
No trades
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.012 AUD
−2.58 M AUD
0.00 AUD
274.59 M
About Bio-Gene Technology Ltd.
Sector
Industry
CEO
Tim Grogan
Website
Headquarters
Melbourne
Founded
1995
IPO date
Nov 29, 2017
Identifiers
2
ISIN AU000000BGT8
Bio-Gene Technology Ltd. engages in the research and development of the next generation of novel insecticides, addressing the problems of insecticide resistance and toxicity. Its novel platform technology is based on occurring beta-triketones, a type of chemistry that may offer solutions for insect management control in animal health and crop protection as well as in public health applications. The company was founded on November 8, 1995 and is headquartered in Melbourne, Australia.
Related stocks
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of BGT is 0.033 AUD — it has decreased by −2.94% in the past 24 hours. Watch Bio-Gene Technology Ltd. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on ASX exchange Bio-Gene Technology Ltd. stocks are traded under the ticker BGT.
BGT stock has fallen by −2.94% compared to the previous week, the month change is a 32.00% rise, over the last year Bio-Gene Technology Ltd. has showed a −19.51% decrease.
BGT stock is 3.03% volatile and has beta coefficient of −0.56. Track Bio-Gene Technology Ltd. stock price on the chart and check out the list of the most volatile stocks — is Bio-Gene Technology Ltd. there?
Today Bio-Gene Technology Ltd. has the market capitalization of 10.07 M, it has decreased by −8.82% over the last week.
Yes, you can track Bio-Gene Technology Ltd. financials in yearly and quarterly reports right on TradingView.
Bio-Gene Technology Ltd. is going to release the next earnings report on Mar 4, 2026. Keep track of upcoming events with our Earnings Calendar.
BGT net income for the last half-year is −1.12 M AUD, while the previous report showed −1.46 M AUD of net income which accounts for 23.56% change. Track more Bio-Gene Technology Ltd. financial stats to get the full picture.
No, BGT doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, BGT shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Bio-Gene Technology Ltd. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Bio-Gene Technology Ltd. technincal analysis shows the strong buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Bio-Gene Technology Ltd. stock shows the sell signal. See more of Bio-Gene Technology Ltd. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.